In cancer, adaptive immune cells such as CD4+ T helper cells and CD8+ T cells are activated through presentation of tumor antigen in Major Histocompatibility Complex (MHC)-Class II and Class I by antigen presenting cells, respectively. Here, CD8A is linked to cancer.